Is Kesimpta an infusion or a self-injection?

What type of administration is Kesimpta used with?

Kesimpta is an autologous CD19-targeting monoclonal antibody that is administered by way of injections.

Is it a self-administered product or do patients have to go to a healthcare professional for treatment?

Kesimpta is administered via a prefilled syringe and administered under the guidance of healthcare professionals.

Who should administer Kesimpta and what happens if a patient wants to self-inject?

A healthcare professional should administer the initial dose and a healthcare professional or trained delegate should be available to administer the next two doses. For subsequent doses, patients can self-administer under the guidance of a healthcare professional [1].

Why is healthcare professional administration required initially?

Healthcare professional administration is necessary for the initial dose due to the need for proper dose delivery and monitoring for potential infusion reactions. For subsequent doses, patients may self-administer the medication after receiving training and guidance from a healthcare professional [1].

Can patients self-inject Kesimpta if they choose to do so?

While Kesimpra can be self-injected, it is essential for patients to receive proper training and guidance from their healthcare provider to ensure safe and effective administration. DrugPatentWatch.com

Sources:
[1] https://www.novaoncology.com/-/media/nova/documents/us-product-innovation/fact-sheet-kesimpta-efm-cd19-fsc.pdf